| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
519,852 |
474,427 |
$23.17M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
249,550 |
219,333 |
$8.19M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
88,198 |
83,718 |
$5.61M |
| 99051 |
|
89,751 |
82,860 |
$1.74M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
18,758 |
17,377 |
$1.21M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
23,030 |
20,609 |
$887K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18,607 |
17,154 |
$732K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12,577 |
11,557 |
$605K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,028 |
10,137 |
$516K |
| 70450 |
Computed tomography, head or brain; without contrast material |
15,939 |
14,383 |
$499K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,448 |
10,444 |
$476K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
13,043 |
8,567 |
$476K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
63,751 |
53,387 |
$460K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
9,215 |
8,415 |
$445K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
5,228 |
4,827 |
$395K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
2,651 |
2,008 |
$383K |
| 20610 |
|
12,434 |
7,938 |
$374K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16,085 |
15,560 |
$362K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,224 |
7,805 |
$334K |
| 71046 |
Radiologic examination, chest; 2 views |
30,634 |
28,810 |
$295K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,447 |
3,272 |
$284K |
| 99215 |
Prolong outpt/office vis |
4,800 |
4,410 |
$266K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,525 |
6,826 |
$258K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
13,357 |
5,174 |
$253K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,416 |
2,235 |
$246K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,502 |
4,218 |
$211K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,664 |
1,889 |
$204K |
| 71045 |
Radiologic examination, chest; single view |
32,118 |
26,728 |
$201K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,371 |
5,468 |
$190K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
11,279 |
10,734 |
$187K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,457 |
3,280 |
$179K |
| J7328 |
Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
997 |
400 |
$166K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
5,683 |
5,422 |
$159K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,926 |
3,524 |
$132K |
| 98940 |
|
9,601 |
5,347 |
$130K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
6,237 |
3,810 |
$124K |
| 71250 |
|
4,453 |
4,014 |
$123K |
| 80053 |
Comprehensive metabolic panel |
14,424 |
12,551 |
$120K |
| 76830 |
Ultrasound, transvaginal |
3,413 |
3,220 |
$114K |
| 36415 |
Collection of venous blood by venipuncture |
32,914 |
27,605 |
$114K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,806 |
15,453 |
$109K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,052 |
1,877 |
$106K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,407 |
1,333 |
$104K |
| 64615 |
|
1,190 |
1,083 |
$102K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,291 |
2,114 |
$96K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,394 |
7,218 |
$96K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,536 |
4,325 |
$95K |
| 73630 |
|
11,566 |
10,026 |
$94K |
| 80061 |
Lipid panel |
10,376 |
9,034 |
$91K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,239 |
4,122 |
$90K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,123 |
4,410 |
$90K |
| 73562 |
|
9,624 |
8,017 |
$89K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,081 |
6,507 |
$82K |
| 80050 |
General health panel |
2,526 |
2,310 |
$80K |
| 92557 |
|
4,041 |
3,355 |
$80K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
870 |
619 |
$75K |
| 72110 |
|
4,773 |
4,531 |
$72K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
122 |
113 |
$70K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,238 |
1,985 |
$70K |
| 72131 |
|
2,050 |
1,834 |
$68K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
387 |
303 |
$65K |
| 59025 |
Fetal non-stress test |
2,657 |
1,921 |
$65K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
8,063 |
7,192 |
$65K |
| 95886 |
|
2,503 |
2,107 |
$64K |
| 73610 |
|
7,441 |
6,778 |
$62K |
| 92015 |
Determination of refractive state |
4,757 |
3,828 |
$61K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,136 |
7,982 |
$61K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
837 |
789 |
$58K |
| 99442 |
|
2,824 |
2,437 |
$57K |
| 88342 |
|
2,342 |
1,950 |
$57K |
| 73030 |
|
6,633 |
5,974 |
$56K |
| 73130 |
|
6,543 |
5,806 |
$56K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
217 |
213 |
$56K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,739 |
1,539 |
$55K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
175 |
158 |
$55K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,130 |
1,054 |
$54K |
| 88141 |
|
1,841 |
1,754 |
$51K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,684 |
2,179 |
$46K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,665 |
1,582 |
$40K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,064 |
1,151 |
$40K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,397 |
1,299 |
$39K |
| 20552 |
|
2,112 |
1,798 |
$39K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,390 |
1,289 |
$39K |
| 70486 |
|
1,026 |
948 |
$39K |
| 99152 |
|
771 |
662 |
$37K |
| 97597 |
|
5,055 |
2,731 |
$36K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
195 |
173 |
$36K |
| 94060 |
|
2,909 |
2,776 |
$36K |
| 73110 |
|
4,081 |
3,677 |
$35K |
| 99233 |
Prolong inpt eval add15 m |
1,333 |
435 |
$35K |
| 0240U |
|
738 |
644 |
$35K |
| 00840 |
|
294 |
180 |
$35K |
| 74018 |
|
4,112 |
3,763 |
$34K |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
403 |
144 |
$34K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,499 |
1,379 |
$31K |
| 92567 |
|
3,778 |
3,191 |
$31K |
| 93458 |
|
222 |
208 |
$30K |
| 93016 |
|
1,492 |
1,405 |
$29K |
| 76536 |
|
1,289 |
1,214 |
$29K |
| 72128 |
|
818 |
720 |
$28K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
941 |
777 |
$27K |
| 82607 |
|
3,315 |
2,747 |
$27K |
| 90686 |
|
6,495 |
6,091 |
$26K |
| 88307 |
|
367 |
337 |
$25K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,789 |
3,151 |
$25K |
| 94010 |
|
2,832 |
2,231 |
$24K |
| 99221 |
|
902 |
836 |
$24K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
515 |
479 |
$24K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
75 |
75 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,288 |
2,875 |
$23K |
| 90961 |
|
443 |
425 |
$22K |
| 99441 |
|
2,033 |
1,722 |
$22K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
480 |
442 |
$22K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
263 |
139 |
$22K |
| 99460 |
|
259 |
212 |
$21K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,907 |
1,376 |
$21K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
130 |
105 |
$21K |
| 99222 |
Initial hospital care, per day, moderate complexity |
372 |
310 |
$20K |
| 73502 |
|
2,232 |
2,067 |
$20K |
| 82746 |
|
2,808 |
2,315 |
$20K |
| 0002A |
|
485 |
474 |
$19K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,965 |
2,666 |
$19K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
627 |
412 |
$19K |
| 0001A |
|
488 |
472 |
$19K |
| 93971 |
|
1,011 |
952 |
$19K |
| 88142 |
|
1,010 |
989 |
$18K |
| 93018 |
|
1,490 |
1,404 |
$18K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
499 |
403 |
$17K |
| 99217 |
|
658 |
640 |
$17K |
| 99177 |
|
2,003 |
1,713 |
$16K |
| 84439 |
|
2,355 |
2,037 |
$16K |
| 95024 |
|
675 |
577 |
$16K |
| 72050 |
|
1,086 |
1,019 |
$16K |
| 99443 |
|
575 |
524 |
$15K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
3,516 |
3,178 |
$15K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
758 |
597 |
$15K |
| 99218 |
|
703 |
657 |
$15K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
515 |
477 |
$15K |
| V5266 |
Battery for use in hearing device |
3,809 |
2,123 |
$14K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
528 |
495 |
$14K |
| 95811 |
|
191 |
188 |
$14K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
348 |
310 |
$14K |
| 76642 |
|
490 |
410 |
$13K |
| 95912 |
|
165 |
146 |
$13K |
| 93227 |
|
474 |
468 |
$13K |
| 93244 |
|
732 |
662 |
$13K |
| 87186 |
|
1,525 |
1,142 |
$13K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
98 |
89 |
$12K |
| 94726 |
|
2,864 |
2,739 |
$11K |
| 81001 |
|
3,593 |
3,175 |
$11K |
| 94729 |
|
2,864 |
2,739 |
$11K |
| 87077 |
|
1,534 |
1,143 |
$11K |
| 69210 |
|
702 |
619 |
$10K |
| 90962 |
|
223 |
196 |
$10K |
| 76770 |
|
442 |
403 |
$10K |
| 88304 |
|
1,023 |
919 |
$10K |
| 90837 |
Psychotherapy, 53 minutes with patient |
120 |
91 |
$10K |
| 31575 |
|
230 |
221 |
$10K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
140 |
136 |
$10K |
| 86803 |
|
895 |
775 |
$9K |
| 71271 |
|
194 |
172 |
$9K |
| 62323 |
|
121 |
118 |
$9K |
| 92133 |
|
1,228 |
966 |
$9K |
| 11750 |
|
118 |
101 |
$8K |
| 81025 |
|
1,228 |
1,125 |
$8K |
| 99174 |
|
640 |
608 |
$8K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
256 |
204 |
$7K |
| 73080 |
|
1,160 |
1,057 |
$7K |
| 83550 |
|
1,330 |
1,112 |
$7K |
| 89190 |
|
1,604 |
1,380 |
$7K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
116 |
107 |
$7K |
| 00731 |
|
140 |
91 |
$7K |
| 87340 |
|
925 |
804 |
$7K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
89 |
81 |
$6K |
| 95909 |
|
135 |
128 |
$6K |
| 83540 |
|
1,493 |
1,246 |
$6K |
| 74019 |
|
626 |
589 |
$6K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
111 |
99 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
373 |
332 |
$6K |
| 92504 |
|
1,426 |
1,230 |
$6K |
| 82570 |
|
1,337 |
1,173 |
$6K |
| 0012A |
|
136 |
136 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
73 |
72 |
$6K |
| 99349 |
|
293 |
283 |
$5K |
| 0031A |
|
171 |
170 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
91 |
85 |
$5K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
31 |
30 |
$5K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
49 |
48 |
$5K |
| 95251 |
|
827 |
738 |
$5K |
| 77066 |
Tomosynthesis, mammo |
159 |
152 |
$5K |
| 86780 |
|
597 |
507 |
$5K |
| 0003A |
|
54 |
54 |
$5K |
| 86140 |
|
1,378 |
1,201 |
$5K |
| 0011A |
|
129 |
129 |
$5K |
| 95911 |
|
66 |
64 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
68 |
58 |
$5K |
| 92587 |
|
287 |
227 |
$5K |
| 36573 |
|
107 |
95 |
$4K |
| 93454 |
|
43 |
38 |
$4K |
| 93880 |
|
211 |
206 |
$4K |
| 00813 |
|
55 |
50 |
$4K |
| 90671 |
|
306 |
186 |
$4K |
| 74178 |
|
69 |
66 |
$4K |
| 82043 |
|
786 |
689 |
$4K |
| 73560 |
|
493 |
408 |
$4K |
| 11721 |
|
913 |
817 |
$4K |
| 72072 |
|
369 |
334 |
$3K |
| 86850 |
|
475 |
405 |
$3K |
| 31237 |
|
35 |
16 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
66 |
54 |
$3K |
| 85610 |
|
1,200 |
945 |
$3K |
| 90677 |
|
121 |
70 |
$3K |
| 73590 |
|
430 |
355 |
$3K |
| 74022 |
|
218 |
195 |
$3K |
| G0127 |
Trimming of dystrophic nails, any number |
1,272 |
1,131 |
$3K |
| 81003 |
|
1,604 |
1,345 |
$3K |
| 99225 |
|
234 |
177 |
$3K |
| 82728 |
|
376 |
311 |
$3K |
| H1000 |
Prenatal care, at-risk assessment |
151 |
137 |
$3K |
| 90670 |
|
4,971 |
4,689 |
$3K |
| 93298 |
|
243 |
191 |
$3K |
| 99336 |
|
400 |
386 |
$3K |
| 64493 |
|
96 |
84 |
$3K |
| 92134 |
|
423 |
273 |
$3K |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
462 |
454 |
$3K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
204 |
132 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
90 |
85 |
$3K |
| 87070 |
|
278 |
250 |
$3K |
| 87420 |
|
187 |
155 |
$2K |
| 90656 |
|
188 |
167 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
77 |
77 |
$2K |
| 20553 |
|
106 |
83 |
$2K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
153 |
137 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
54 |
37 |
$2K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
28 |
13 |
$2K |
| 93970 |
|
107 |
104 |
$2K |
| 85652 |
|
1,103 |
969 |
$2K |
| 90715 |
|
339 |
284 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
38 |
38 |
$2K |
| 73090 |
|
256 |
232 |
$2K |
| 95117 |
|
515 |
217 |
$2K |
| 92002 |
|
110 |
103 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
63 |
55 |
$2K |
| 20605 |
|
69 |
63 |
$2K |
| 70496 |
|
37 |
27 |
$2K |
| 81000 |
|
413 |
362 |
$2K |
| 31231 |
|
44 |
37 |
$2K |
| 20550 |
|
61 |
56 |
$2K |
| 82947 |
|
479 |
406 |
$2K |
| 00811 |
|
40 |
24 |
$2K |
| 70491 |
|
28 |
26 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
34 |
30 |
$2K |
| 92083 |
|
158 |
137 |
$2K |
| 64632 |
|
48 |
38 |
$2K |
| 83735 |
|
341 |
264 |
$1K |
| 90648 |
|
5,713 |
5,232 |
$1K |
| 93228 |
|
92 |
83 |
$1K |
| 80306 |
|
129 |
85 |
$1K |
| 90662 |
|
119 |
109 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
117 |
108 |
$1K |
| 85018 |
|
461 |
422 |
$1K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
61 |
54 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
286 |
272 |
$1K |
| 90832 |
Psychotherapy, 30 minutes with patient |
26 |
24 |
$1K |
| 43235 |
|
16 |
13 |
$1K |
| 90791 |
Psychiatric diagnostic evaluation |
13 |
13 |
$1K |
| 93272 |
|
33 |
28 |
$997.63 |
| 20551 |
|
38 |
24 |
$992.11 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
345 |
282 |
$988.00 |
| 73140 |
|
129 |
114 |
$970.20 |
| 70498 |
|
19 |
15 |
$964.87 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,162 |
316 |
$964.74 |
| 95908 |
|
28 |
26 |
$962.05 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
182 |
159 |
$881.55 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
63 |
53 |
$881.36 |
| 90723 |
|
3,440 |
3,147 |
$870.76 |
| 93295 |
|
45 |
41 |
$863.05 |
| 83992 |
|
58 |
48 |
$844.78 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
30 |
27 |
$840.88 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
150 |
121 |
$827.19 |
| 80346 |
|
40 |
35 |
$825.22 |
| 71101 |
|
85 |
76 |
$816.10 |
| 90651 |
|
322 |
274 |
$795.30 |
| 99401 |
|
26 |
26 |
$792.12 |
| 59430 |
|
13 |
13 |
$792.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
53 |
53 |
$754.54 |
| 64450 |
|
13 |
13 |
$753.23 |
| 86038 |
|
91 |
79 |
$738.09 |
| 80361 |
|
40 |
35 |
$712.58 |
| 99337 |
|
101 |
100 |
$689.43 |
| 80363 |
|
32 |
30 |
$672.58 |
| 99406 |
|
85 |
79 |
$640.94 |
| 99205 |
Prolong outpt/office vis |
16 |
13 |
$638.04 |
| 87522 |
Neg quan hep c or qual rna |
17 |
12 |
$610.45 |
| 88112 |
|
31 |
25 |
$540.00 |
| 93294 |
|
44 |
38 |
$539.57 |
| 86762 |
|
62 |
50 |
$514.32 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
133 |
124 |
$508.04 |
| 86703 |
|
95 |
71 |
$504.37 |
| 86706 |
|
57 |
49 |
$502.41 |
| 51798 |
|
80 |
75 |
$497.25 |
| 98928 |
|
13 |
12 |
$478.96 |
| 73564 |
|
45 |
36 |
$472.27 |
| 27096 |
|
12 |
12 |
$461.79 |
| 86769 |
|
18 |
16 |
$446.57 |
| 83690 |
|
107 |
72 |
$439.48 |
| 90734 |
|
939 |
870 |
$439.44 |
| 84153 |
|
32 |
24 |
$421.24 |
| 99335 |
|
65 |
48 |
$419.62 |
| 11055 |
|
79 |
62 |
$418.54 |
| 93922 |
|
31 |
28 |
$414.90 |
| 80350 |
|
40 |
35 |
$413.38 |
| 80358 |
|
41 |
35 |
$413.38 |
| 80353 |
|
40 |
35 |
$413.38 |
| 80324 |
|
40 |
35 |
$413.38 |
| 80349 |
|
40 |
35 |
$413.38 |
| 80373 |
|
40 |
35 |
$413.38 |
| 80348 |
|
40 |
35 |
$413.38 |
| 80356 |
|
40 |
35 |
$413.38 |
| 80355 |
|
39 |
34 |
$413.38 |
| 80365 |
|
40 |
35 |
$413.38 |
| 80354 |
|
40 |
35 |
$413.38 |
| 52000 |
|
14 |
12 |
$406.02 |
| 93280 |
|
41 |
37 |
$383.17 |
| 90633 |
|
1,684 |
1,562 |
$378.16 |
| 86666 |
|
30 |
12 |
$374.29 |
| 92136 |
|
47 |
40 |
$374.13 |
| 99219 |
|
12 |
12 |
$362.63 |
| 80368 |
|
32 |
30 |
$358.53 |
| 80359 |
|
32 |
30 |
$358.53 |
| 80333 |
|
32 |
30 |
$358.53 |
| 80367 |
|
32 |
30 |
$358.53 |
| 80371 |
|
32 |
30 |
$358.53 |
| 80336 |
|
32 |
30 |
$358.53 |
| 80372 |
|
32 |
30 |
$358.53 |
| 80360 |
|
32 |
30 |
$358.53 |
| 80366 |
|
32 |
30 |
$358.53 |
| 80369 |
|
32 |
30 |
$358.53 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,739 |
1,647 |
$344.78 |
| 80323 |
|
32 |
30 |
$336.31 |
| 86757 |
|
30 |
12 |
$324.96 |
| 84403 |
|
19 |
14 |
$309.72 |
| 99407 |
|
18 |
15 |
$297.11 |
| 90710 |
|
319 |
281 |
$296.07 |
| 83655 |
|
26 |
26 |
$283.40 |
| 84550 |
|
125 |
107 |
$277.34 |
| 90474 |
|
25 |
24 |
$241.78 |
| 96127 |
|
84 |
56 |
$240.63 |
| 99224 |
|
12 |
12 |
$231.17 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
38 |
25 |
$214.93 |
| 76882 |
|
28 |
26 |
$212.52 |
| 87210 |
|
50 |
46 |
$211.25 |
| 86430 |
|
54 |
38 |
$196.32 |
| 84702 |
|
18 |
13 |
$189.70 |
| 85014 |
|
75 |
56 |
$181.29 |
| 95012 |
|
34 |
25 |
$178.53 |
| 86376 |
|
24 |
14 |
$174.52 |
| 86618 |
|
40 |
27 |
$173.69 |
| 85730 |
|
44 |
39 |
$164.69 |
| 85027 |
|
34 |
24 |
$161.10 |
| 80069 |
|
15 |
14 |
$127.17 |
| 86900 |
|
71 |
62 |
$124.15 |
| 82150 |
|
71 |
42 |
$123.55 |
| 90681 |
|
625 |
575 |
$123.02 |
| 86901 |
|
71 |
62 |
$117.15 |
| 93000 |
|
12 |
12 |
$113.92 |
| 97014 |
|
520 |
141 |
$101.00 |
| 99334 |
|
40 |
33 |
$98.48 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$91.74 |
| 73565 |
|
12 |
12 |
$85.20 |
| 82247 |
|
16 |
12 |
$69.37 |
| 77080 |
|
16 |
12 |
$59.37 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
53 |
53 |
$46.41 |
| 85007 |
|
13 |
12 |
$41.05 |
| 81002 |
|
16 |
14 |
$39.71 |
| 99000 |
|
24 |
12 |
$28.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
18 |
15 |
$26.84 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
71 |
67 |
$25.18 |
| 1034F |
|
44,713 |
37,353 |
$24.51 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
13 |
$22.99 |
| 3078F |
|
156,012 |
135,273 |
$19.23 |
| 84436 |
|
14 |
12 |
$17.51 |
| 84156 |
|
14 |
14 |
$15.14 |
| 90696 |
|
207 |
176 |
$10.08 |
| 97032 |
|
82 |
25 |
$9.41 |
| 97035 |
|
87 |
25 |
$7.98 |
| 1036F |
|
194,951 |
166,311 |
$5.61 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$1.06 |
| 90716 |
|
37 |
37 |
$0.02 |
| 90707 |
|
49 |
37 |
$0.01 |
| 1160F |
|
264,530 |
225,879 |
$0.01 |
| 1159F |
|
236,370 |
200,481 |
$0.01 |
| 1126F |
|
83,797 |
74,016 |
$0.00 |
| 1125F |
|
82,818 |
70,205 |
$0.00 |
| 3075F |
|
19,445 |
17,257 |
$0.00 |
| 3008F |
|
236,842 |
204,571 |
$0.00 |
| 1035F |
|
7,052 |
5,792 |
$0.00 |
| 3074F |
|
164,756 |
142,392 |
$0.00 |
| 3079F |
|
39,944 |
35,360 |
$0.00 |
| 3080F |
|
4,751 |
4,204 |
$0.00 |
| 3725F |
|
112,957 |
98,331 |
$0.00 |
| 3077F |
|
12,634 |
11,232 |
$0.00 |
| 3288F |
|
8,877 |
7,687 |
$0.00 |
| 90649 |
|
65 |
64 |
$0.00 |
| 90700 |
|
50 |
38 |
$0.00 |
| 1124F |
|
28 |
24 |
$0.00 |